DANIELLE GUZI: Open Payments
NPI 1467199430 · CLINTON TWP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 23 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $96 |
| Globus Medical, Inc. | 2 | $88 |
| ABBVIE INC. | 4 | $80 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $46 |
| TG Therapeutics, Inc. | 1 | $35 |
| CSL Behring | 1 | $31 |
| GENZYME CORPORATION | 1 | $27 |
| UCB, Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $22 |
Products named: HYQVIA, LUMRYZ, OMNIA, Senza, BOTOX, BRIUMVI, Hizentra, Briviact.
Industry payments across MI — which companies pay providers there.
